Flow cytometry demonstrated that P2X4R-expressing TAMs not only enhanced CD8+ T cell survival and cytotoxicity in vitro but also augmented T cell responses in a syngeneic CRC mouse model. Here, CD8A is linked to colorectal carcinoma.